Y. Weng

发表

Wilms’ tumour suppressor gene 1 (WT1) is involved in the carcinogenesis of Lung cancer through interaction with PI3K/Akt pathway

X. Chen, P. Gao, K. Dong, 2013, Cancer Cell International.

Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness.

L. Qin, X. Jiang, Z. Tang, 1998, Chinese medical journal.

The synergistic anti-tumor effect of iodine-125 low-dose-rate brachytherapy and anti-PD-1 therapy on lung cancer in mice

Jia Li, H. Pang, Yiyi Cao, 2020 .

Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer

Jianwei Zhou, Hongchuan Jin, Xian Wang, 2017, Oncotarget.

microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.

P. Gao, K. Dong, F. Lin, 2013, Cancer biotherapy & radiopharmaceuticals.

Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia.

X. Chen, K. Dong, Ting He, 2015, Cellular signalling.

Wilms’ tumour suppressor gene 1 (WT1) is involved in the carcinogenesis of Lung cancer through interaction with PI3K/Akt pathway

X. Chen, P. Gao, K. Dong, 2013, Cancer Cell International.

Chemotherapy agents-induced immunoresistance in lung cancer cells could be reversed by trop-2 inhibition in vitro and in vivo by interaction with MAPK signaling pathway

X. Chen, K. Dong, Ting He, 2013, Cancer biology & therapy.